Loading…
image

Report Scope & Overview:

Ophthalmic Viscoelastic Agent Market Overview:
Global Ophthalmic Viscoelastic Agent Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Ophthalmic Viscoelastic Agent Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
 

Ophthalmic Viscoelastic Agent Market Key Trends

Growing Demand for Cataract Surgery: The primary application of ophthalmic viscoelastic agents is in cataract surgery. As the global population ages, the demand for cataract surgery increases, driving the market for OVDs.

Advancements in OVD Technology: Ongoing advancements in ophthalmic viscoelastic agent technology aim to improve the properties of these agents, such as enhanced viscosity, better dispersive and cohesive properties, and longer duration of action during surgery.

Shift Towards Premium OVDs: There is a trend towards the use of premium ophthalmic viscoelastic agents that offer superior performance and safety profiles. Surgeons and ophthalmologists may prefer premium OVDs for complex surgeries and premium intraocular lens (IOL) implantations.

Introduction of Preloaded Syringes: Some manufacturers are introducing preloaded syringes for ophthalmic viscoelastic agents. Preloaded syringes can simplify the surgical process, reduce the risk of contamination, and improve overall efficiency in the operating room.

Rise in Minimally Invasive Ophthalmic Procedures: The market for ophthalmic viscoelastic agents is influenced by the increasing adoption of minimally invasive ophthalmic procedures. OVDs play a crucial role in facilitating these procedures, including micro-incision cataract surgery.

Expansion of Applications Beyond Cataract Surgery: Ophthalmic viscoelastic agents are finding applications beyond cataract surgery. They may be used in other ophthalmic procedures, such as glaucoma surgery, corneal transplantation, and certain retinal surgeries.

Focus on Patient Safety and Comfort: There is a growing emphasis on patient safety and comfort during ophthalmic surgeries. OVD manufacturers are working on formulations that provide effective protection to intraocular tissues while minimizing potential side effects.

Market Segmentations:
Global Ophthalmic Viscoelastic Agent Market: By Company
• Alcon Inc
• Shanghai Haohai Biological Technology
• Bausch & Lomb Inc
• Abbott Medical Optics,Inc.
• LG Life Sciences
• Johnson & Johnson Vision
• Zeiss
• Ellex Medical Laser Limited
• Huvitz Co., Ltd.
• Iridex Corp.
• Lumenis Ltd.
• Nidek Co. Ltd
• Topcon Corporation
• Visionix Ltd
• Eyebright Medical

Global Ophthalmic Viscoelastic Agent Market: By Type
• Cohesive Viscoelastic
• Low Viscosity Dispersion Viscoelastic

Global Ophthalmic Viscoelastic Agent Market: By Application
• Cataract Surgery
• Myopia Surgery
• Other


Global Ophthalmic Viscoelastic Agent Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Ophthalmic Viscoelastic Agent market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Report Attribute/MetricDetails
Base Year2022
Forecast Period2023-2032
Historical Data2018-2022
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
By Type• Cohesive Viscoelastic
• Low Viscosity Dispersion Viscoelastic
By Application• Cataract Surgery
• Myopia Surgery
Key Companies Profiled• Alcon Inc
• Shanghai Haohai Biological Technology
• Bausch & Lomb Inc
• Abbott Medical Optics,Inc.
• LG Life Sciences
• Johnson & Johnson Vision
• Zeiss
• Ellex Medical Laser Limited
• Huvitz Co., Ltd.
• Iridex Corp.
• Lumenis Ltd.
• Nidek Co. Ltd
• Topcon Corporation
• Visionix Ltd
• Eyebright Medical
Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America
Customization ScopeAvailable on Request

Reasons to Purchase Ophthalmic Viscoelastic Agent Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.

Objectives of Ophthalmic Viscoelastic Agent Market Study:
The objectives of Ophthalmic Viscoelastic Agent market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Ophthalmic Viscoelastic Agent market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.

Frequently Asked Questions

TABLE OF CONTENT

1 Ophthalmic Viscoelastic Agent Market Overview
1.1 Product Overview and Scope of Ophthalmic Viscoelastic Agent
1.2 Ophthalmic Viscoelastic Agent Segment by Type
1.2.1 Global Ophthalmic Viscoelastic Agent Market Value Comparison by Type (2023-2032)
1.2.2 Cohesive Viscoelastic
1.2.3 Low Viscosity Dispersion Viscoelastic
1.3 Ophthalmic Viscoelastic Agent Segment by Application
1.3.1 Global Ophthalmic Viscoelastic Agent Market Value by Application: (2023-2032)
1.3.2 Cataract Surgery
1.3.3 Myopia Surgery
1.3.4 Other
1.4 Global Ophthalmic Viscoelastic Agent Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Viscoelastic Agent Revenue 2017-2032
1.4.2 Global Ophthalmic Viscoelastic Agent Sales 2017-2032
1.4.3 Global Ophthalmic Viscoelastic Agent Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Ophthalmic Viscoelastic Agent Market Competition by Manufacturers
2.1 Global Ophthalmic Viscoelastic Agent Sales Market Share by Manufacturers (2017-2023)
2.2 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Ophthalmic Viscoelastic Agent Average Price by Manufacturers (2017-2023)
2.4 Global Ophthalmic Viscoelastic Agent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Ophthalmic Viscoelastic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmic Viscoelastic Agent, Product Type & Application
2.7 Ophthalmic Viscoelastic Agent Market Competitive Situation and Trends
2.7.1 Ophthalmic Viscoelastic Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ophthalmic Viscoelastic Agent Players Market Share by Revenue
2.7.3 Global Ophthalmic Viscoelastic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmic Viscoelastic Agent Retrospective Market Scenario by Region
3.1 Global Ophthalmic Viscoelastic Agent Market Size by Region: 2017 Versus 2022 Versus 2032
3.2 Global Ophthalmic Viscoelastic Agent Global Ophthalmic Viscoelastic Agent Sales by Region: 2017-2032
3.2.1 Global Ophthalmic Viscoelastic Agent Sales by Region: 2017-2023
3.2.2 Global Ophthalmic Viscoelastic Agent Sales by Region: 2023-2032
3.3 Global Ophthalmic Viscoelastic Agent Global Ophthalmic Viscoelastic Agent Revenue by Region: 2017-2032
3.3.1 Global Ophthalmic Viscoelastic Agent Revenue by Region: 2017-2023
3.3.2 Global Ophthalmic Viscoelastic Agent Revenue by Region: 2023-2032
3.4 North America Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.4.1 North America Ophthalmic Viscoelastic Agent Market Size by Country: 2017 VS 2022 VS 2032
3.4.2 North America Ophthalmic Viscoelastic Agent Sales by Country (2017-2032)
3.4.3 North America Ophthalmic Viscoelastic Agent Revenue by Country (2017-2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.5.1 Europe Ophthalmic Viscoelastic Agent Market Size by Country: 2017 VS 2022 VS 2032
3.5.2 Europe Ophthalmic Viscoelastic Agent Sales by Country (2017-2032)
3.5.3 Europe Ophthalmic Viscoelastic Agent Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Ophthalmic Viscoelastic Agent Market Size by Country: 2017 VS 2022 VS 2032
3.6.2 Asia Pacific Ophthalmic Viscoelastic Agent Sales by Country (2017-2032)
3.6.3 Asia Pacific Ophthalmic Viscoelastic Agent Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.7.1 Latin America Ophthalmic Viscoelastic Agent Market Size by Country: 2017 VS 2022 VS 2032
3.7.2 Latin America Ophthalmic Viscoelastic Agent Sales by Country (2017-2032)
3.7.3 Latin America Ophthalmic Viscoelastic Agent Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmic Viscoelastic Agent Market Size by Country: 2017 VS 2022 VS 2032
3.8.2 Middle East and Africa Ophthalmic Viscoelastic Agent Sales by Country (2017-2032)
3.8.3 Middle East and Africa Ophthalmic Viscoelastic Agent Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ophthalmic Viscoelastic Agent Sales by Type (2017-2032)
4.1.1 Global Ophthalmic Viscoelastic Agent Sales by Type (2017-2023)
4.1.2 Global Ophthalmic Viscoelastic Agent Sales by Type (2023-2032)
4.1.3 Global Ophthalmic Viscoelastic Agent Sales Market Share by Type (2017-2032)
4.2 Global Ophthalmic Viscoelastic Agent Revenue by Type (2017-2032)
4.2.1 Global Ophthalmic Viscoelastic Agent Revenue by Type (2017-2023)
4.2.2 Global Ophthalmic Viscoelastic Agent Revenue by Type (2023-2032)
4.2.3 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Type (2017-2032)
4.3 Global Ophthalmic Viscoelastic Agent Price by Type (2017-2032)
5 Segment by Application
5.1 Global Ophthalmic Viscoelastic Agent Sales by Application (2017-2032)
5.1.1 Global Ophthalmic Viscoelastic Agent Sales by Application (2017-2023)
5.1.2 Global Ophthalmic Viscoelastic Agent Sales by Application (2023-2032)
5.1.3 Global Ophthalmic Viscoelastic Agent Sales Market Share by Application (2017-2032)
5.2 Global Ophthalmic Viscoelastic Agent Revenue by Application (2017-2032)
5.2.1 Global Ophthalmic Viscoelastic Agent Revenue by Application (2017-2023)
5.2.2 Global Ophthalmic Viscoelastic Agent Revenue by Application (2023-2032)
5.2.3 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Application (2017-2032)
5.3 Global Ophthalmic Viscoelastic Agent Price by Application (2017-2032)
6 Key Companies Profiled
6.1 Alcon Inc
6.1.1 Alcon Inc Corporation Information
6.1.2 Alcon Inc Description and Business Overview
6.1.3 Alcon Inc Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Alcon Inc Ophthalmic Viscoelastic Agent Product Portfolio
6.1.5 Alcon Inc Recent Developments/Updates
6.2 Shanghai Haohai Biological Technology
6.2.1 Shanghai Haohai Biological Technology Corporation Information
6.2.2 Shanghai Haohai Biological Technology Description and Business Overview
6.2.3 Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Product Portfolio
6.2.5 Shanghai Haohai Biological Technology Recent Developments/Updates
6.3 Bausch & Lomb Inc
6.3.1 Bausch & Lomb Inc Corporation Information
6.3.2 Bausch & Lomb Inc Description and Business Overview
6.3.3 Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Product Portfolio
6.3.5 Bausch & Lomb Inc Recent Developments/Updates
6.4 Abbott Medical Optics,Inc.
6.4.1 Abbott Medical Optics,Inc. Corporation Information
6.4.2 Abbott Medical Optics,Inc. Description and Business Overview
6.4.3 Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Product Portfolio
6.4.5 Abbott Medical Optics,Inc. Recent Developments/Updates
6.5 LG Life Sciences
6.5.1 LG Life Sciences Corporation Information
6.5.2 LG Life Sciences Description and Business Overview
6.5.3 LG Life Sciences Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.5.4 LG Life Sciences Ophthalmic Viscoelastic Agent Product Portfolio
6.5.5 LG Life Sciences Recent Developments/Updates
6.6 Johnson & Johnson Vision
6.6.1 Johnson & Johnson Vision Corporation Information
6.6.2 Johnson & Johnson Vision Description and Business Overview
6.6.3 Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Product Portfolio
6.6.5 Johnson & Johnson Vision Recent Developments/Updates
6.7 Zeiss
6.6.1 Zeiss Corporation Information
6.6.2 Zeiss Description and Business Overview
6.6.3 Zeiss Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Zeiss Ophthalmic Viscoelastic Agent Product Portfolio
6.7.5 Zeiss Recent Developments/Updates
6.8 Ellex Medical Laser Limited
6.8.1 Ellex Medical Laser Limited Corporation Information
6.8.2 Ellex Medical Laser Limited Description and Business Overview
6.8.3 Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Product Portfolio
6.8.5 Ellex Medical Laser Limited Recent Developments/Updates
6.9 Huvitz Co., Ltd.
6.9.1 Huvitz Co., Ltd. Corporation Information
6.9.2 Huvitz Co., Ltd. Description and Business Overview
6.9.3 Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Product Portfolio
6.9.5 Huvitz Co., Ltd. Recent Developments/Updates
6.10 Iridex Corp.
6.10.1 Iridex Corp. Corporation Information
6.10.2 Iridex Corp. Description and Business Overview
6.10.3 Iridex Corp. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Iridex Corp. Ophthalmic Viscoelastic Agent Product Portfolio
6.10.5 Iridex Corp. Recent Developments/Updates
6.11 Lumenis Ltd.
6.11.1 Lumenis Ltd. Corporation Information
6.11.2 Lumenis Ltd. Ophthalmic Viscoelastic Agent Description and Business Overview
6.11.3 Lumenis Ltd. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.11.4 Lumenis Ltd. Ophthalmic Viscoelastic Agent Product Portfolio
6.11.5 Lumenis Ltd. Recent Developments/Updates
6.12 Nidek Co. Ltd
6.12.1 Nidek Co. Ltd Corporation Information
6.12.2 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Description and Business Overview
6.12.3 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Product Portfolio
6.12.5 Nidek Co. Ltd Recent Developments/Updates
6.13 Topcon Corporation
6.13.1 Topcon Corporation Corporation Information
6.13.2 Topcon Corporation Ophthalmic Viscoelastic Agent Description and Business Overview
6.13.3 Topcon Corporation Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Topcon Corporation Ophthalmic Viscoelastic Agent Product Portfolio
6.13.5 Topcon Corporation Recent Developments/Updates
6.14 Visionix Ltd
6.14.1 Visionix Ltd Corporation Information
6.14.2 Visionix Ltd Ophthalmic Viscoelastic Agent Description and Business Overview
6.14.3 Visionix Ltd Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.14.4 Visionix Ltd Ophthalmic Viscoelastic Agent Product Portfolio
6.14.5 Visionix Ltd Recent Developments/Updates
6.15 Eyebright Medical
6.15.1 Eyebright Medical Corporation Information
6.15.2 Eyebright Medical Ophthalmic Viscoelastic Agent Description and Business Overview
6.15.3 Eyebright Medical Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2017-2023)
6.15.4 Eyebright Medical Ophthalmic Viscoelastic Agent Product Portfolio
6.15.5 Eyebright Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmic Viscoelastic Agent Industry Chain Analysis
7.2 Ophthalmic Viscoelastic Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmic Viscoelastic Agent Production Mode & Process
7.4 Ophthalmic Viscoelastic Agent Sales and Marketing
7.4.1 Ophthalmic Viscoelastic Agent Sales Channels
7.4.2 Ophthalmic Viscoelastic Agent Distributors
7.5 Ophthalmic Viscoelastic Agent Customers
8 Ophthalmic Viscoelastic Agent Market Dynamics
8.1 Ophthalmic Viscoelastic Agent Industry Trends
8.2 Ophthalmic Viscoelastic Agent Market Drivers
8.3 Ophthalmic Viscoelastic Agent Market Challenges
8.4 Ophthalmic Viscoelastic Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Alcon Inc
Shanghai Haohai Biological Technology
Bausch & Lomb Inc
Abbott Medical Optics,Inc.
LG Life Sciences
Johnson & Johnson Vision
Zeiss
Ellex Medical Laser Limited
Huvitz Co., Ltd.
Iridex Corp.
Lumenis Ltd.
Nidek Co. Ltd
Topcon Corporation
Visionix Ltd
Eyebright Medical
Request Sample